Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lifecore Biomedical (LFCR) Assets: 2011-2025

Historic Assets for Lifecore Biomedical (LFCR) over the last 15 years, with May 2025 value amounting to $239.3 million.

  • Lifecore Biomedical's Assets fell 5.76% to $239.3 million in Q2 2025 from the same period last year, while for May 2025 it was $239.3 million, marking a year-over-year decrease of 5.76%. This contributed to the annual value of $239.3 million for FY2025, which is 5.76% down from last year.
  • Per Lifecore Biomedical's latest filing, its Assets stood at $239.3 million for FY2025, which was down 5.76% from $254.0 million recorded in FY2024.
  • Over the past 5 years, Lifecore Biomedical's Assets peaked at $501.9 million during FY2021, and registered a low of $239.3 million during FY2025.
  • Over the past 3 years, Lifecore Biomedical's median Assets value was $253.5 million (recorded in 2023), while the average stood at $248.9 million.
  • Its Assets has fluctuated over the past 5 years, first soared by 71.00% in 2021, then crashed by 45.27% in 2022.
  • Over the past 5 years, Lifecore Biomedical's Assets (Yearly) stood at $501.9 million in 2021, then plummeted by 45.27% to $274.7 million in 2022, then dropped by 7.70% to $253.5 million in 2023, then climbed by 0.16% to $254.0 million in 2024, then fell by 5.76% to $239.3 million in 2025.